We presented a dual-targeting nanomedicine approach for cancer therapy using MGO-PEG-CET/DOX that combines co-precipitated Fe3O4 magnetic nanoparticles and CET (an EGFR antibody) for magnetic and receptor-mediated ligand-targeting of malignant CT-26 mouse colon carcinoma. Here, EGFR is linked to cancer.